G
Geraldine S. Pinkus
Researcher at Brigham and Women's Hospital
Publications - 286
Citations - 29136
Geraldine S. Pinkus is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Lymphoma & Immunoperoxidase. The author has an hindex of 84, co-authored 278 publications receiving 27112 citations. Previous affiliations of Geraldine S. Pinkus include University of Texas MD Anderson Cancer Center & Montreal General Hospital.
Papers
More filters
Journal ArticleDOI
Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome.
Lawrence N. Shulman,B Frisard,Joseph H. Antin,C Wheeler,Geraldine S. Pinkus,N Magauran,Peter Mauch,E Nobles,R Mashal,George P. Canellos +9 more
TL;DR: Patients with Ki-1 ALCL have a high frequency of advanced-stage disease and extranodal involvement and are more likely to have tumors of T-cell phenotype than patients with large-cell lymphoma, however, response to standard lymphoma chemotherapy is similar to other patients withLarge-cellymphoma, with a high remission rate in early- stage disease.
Journal ArticleDOI
Hodgkin’s Disease in the Elderly
TL;DR: Patients with Hodgkin’s disease presenting after age 60 were analyzed retrospectively for clinical presentation, distribution of disease, and histopathology, and compared to a younger control group.
Journal Article
Lineage-restricted clonality in biphasic solid tumors.
TL;DR: The findings support redesignation of pulmonary chondroid hamartomas as 'pulmonary chondromas' and suggest that carcinomas developing within fibroadenomas arise from reactive epithelial proliferation, which is useful in the development of novel therapeutic approaches that selectively target neoplastic populations within solid tumors.
Journal ArticleDOI
Immunohistochemical demonstration of epithelial differentiation in adamantinoma of the tibia.
Juan Rosai,Geraldine S. Pinkus +1 more
TL;DR: The results strongly suggest that the cells of tibial adamantinomas are of epithelial rather than endothelial nature, thus confirming previous light- microscopic observations and electron-microscopic studies performed on this tumor.
Journal ArticleDOI
A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68)
TL;DR: Because of its specificity as a histiocyte marker, KP-1 is a useful component in a panel of antibodies for the characterization of soft-tissue sarcomas and the diagnosis of MFH.